Neurological Disorder Diagnostics Market is valued around USD 11305.69 Million in 2018 and expected to reach USD 18273.57 Million by 2025 with the CAGR of 7.1% over the forecast period.
Neurological disorder diagnostics are the various medical devices used for the diagnosis of various neurological disorders such as Parkinson’s disease, Alzheimer’s disease. These medical devices include various imaging devices such as CT Scan, magnetic resonance imaging, biopsy and others. Increasing prevalence of these disorders has led to the increased demand for better diagnostics and better treatment over the period of time. During the study of global neurological disorder diagnostics market, we have considered neurological disorder and end-user to analyze the market.
Global neurological disorder diagnostics market report is segmented on the basis of disorder type, technology type, end-user and by regional & country level. Based upon disorder type, global neurological disorder diagnostics market is classified into genetic neurological disorders, immunological neurological disorders, paraneoplastic syndrome, paraproteinemic neuropathies, and others. Based upon technology type, global neurological disorder diagnostics market is classified as imaging, and in vitro diagnostics. Based upon end-user, global neurological disorder diagnostics market is classified as hopistals, ambulatory surgical centers, diagnostics centers and others.
The regions covered in this neurological disorder diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Neurological Disorder Diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Neurological Disorder Diagnostics Market Reports–
Global neurological disorder diagnostics market report covers prominent players like Koninklijke Philips N.V., Masimo Corporation, York Instruments Ltd., Esaote SpA, Neusoft Medical Systems, NeuroLogica Corporation, General Electric Company, Canon Medical Systems Corporation and others.
Browse The Full Report@ https://www.brandessenceresearch.com/healthcare/neurological-disorder-diagnostics-market/
Increase in the Prevalence of Neurological Disorders and Technological Advancements
The commercialization and growth of global neurological disorders diagnostics market over the past 25 years has been highly impactful. One of the major factors expected to drive the growth of neurological disorders diagnostics market over the forecast period is increase in the prevalence of neurological disorders and others coupled with increased awareness among people. As per Alzheimer’s Association 2018 report, there were around 5.7million of Americans living with Alzheimer’s dementia in 2018 which includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s. Moreover, increase in various technological advancements for the development of novel diagnostics tools which will further helps in the better diagnosis of neurological disorders. Moreover, various collaborations among major market players over the period of time are also expected to promote the growth of neurological disorder diagnostics over the forecast period. However, high costs of these medical devices are expected to hinder the growth of neurological disorder diagnostics market.
North America is Expected to Dominate the Neurological Disorder Diagnostics Market
North America is expected to dominate the market with highest market share over the forecast period due to high adoption of such medical devices and advanced healthcare facilities in this region for disease diagnosis. Europe is expected to the second largest growing region over the forecast period due to the technological advancements and development of new and advanced medical devices. Asia Pacific is expected to be the third largest and fastest growing region over the forecast period owing to large patient pool, increase in per capita income and rapidly growing healthcare industry. Latin America, Middle East and Africa are expected to develop considerably over the forecast period.
Key Benefits for Global Neurological Disorder Diagnostics Market Reports –Global market report covers in depth historical and forecast analysis.
- Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global market report helps to identify opportunities in market place.
- Global market report covers extensive analysis of emerging trends and competitive landscape.
Neurological Disorder Diagnostics Market Segmentation –
By Disorder Type
- Genetic Neurological Disorders
- Immunological Neurological Disorders
- Paraneoplastic Syndrome
- Paraproteinemic Neuropathies
By Technology Type
- In Vitro Diagnostics
By End-User Analysis
- Ambulatory Surgical Centers
- Diagnostics Centers
- North America
- Asia Pacific
- Southeast Asia
- Latin America
- Middle East and Africa
- Rest of Middle East and Africa
Neurological Disorder Diagnostics Market Key Players
Koninklijke Philips N.V.
York Instruments Ltd.
Neusoft Medical Systems
General Electric Company
Canon Medical Systems Corporation